Table of Content

1 Market Overview

• 1.1 Market Segment Overview
  • 1.1.1 Product Definition
  • 1.1.2 Market by Type
    • 1.1.2.1 BA-0702
    • 1.1.2.2 CDX-3379
    • 1.1.2.3 Elgemtumab
    • 1.1.2.4 ETBX-031
    • 1.1.2.5 Others
  • 1.1.3 Market by Application
    • 1.1.3.1 Non-Small Cell Carcinoma
    • 1.1.3.2 Solid Tumor
    • 1.1.3.3 Melanoma
    • 1.1.3.4 Colorectal Cancer
    • 1.1.3.5 Others
• 1.2 Global and China Market Size
  • 1.2.1 Global Overview
  • 1.2.2 China Overview

2 Global and China Market by Company

• 2.1 Global
  • 2.1.1 Global Sales by Company
  • 2.1.2 Global Price by Company
• 2.2 China
  • 2.2.1 China Sales by Company
  • 2.2.2 China Price by Company

3 Global and China Market by Type

• 3.1 Global
  • 3.1.1 Global Sales by Type
  • 3.1.2 Global Price by Type
• 3.2 China
  • 3.2.1 China Sales by Type
  • 3.2.2 China Price by Type

4 Global and China Market by Application

• 4.1 Global
  • 4.1.1 Global Sales by Application
  • 4.1.2 Global Price by Application
• 4.2 China
  • 4.2.1 China Sales by Application
  • 4.2.2 China Price by Application

5 China Trade

• 5.1 Export
• 5.2 Import

6 Key Manufacturers

• 6.1 AstraZeneca Plc
  • 6.1.1 Company Information
  • 6.1.2 Product Specifications
  • 6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 6.2 AVEO Pharmaceuticals, Inc.
• 6.3 Etubics Corporation
• 6.4 F. Hoffmann-La Roche Ltd.
• 6.5 GamaMabs Pharma S.A.
• 6.6 GlaxoSmithKline Plc
• 6.7 Hanmi Pharmaceuticals, Co. Ltd.
• 6.8 ImmunoGen, Inc.
• 6.9 Kolltan Pharmaceuticals, Inc.
• 6.10 Merrimack Pharmaceuticals, Inc.
• 6.11 Merus B.V.
• 6.12 Novartis AG
• 6.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
• 6.14 Sihuan Pharmaceutical Holdings Group Ltd.
• 6.15 Sorrento Therapeutics, Inc.
• 6.16 Symphogen A/S
• 6.17 Takis S.r.l.

7 Industry Upstream

• 7.1 Industry Chain
• 7.2 Raw Materials

8 Market Environment

• 8.1 SWOT
• 8.2 Porter's Five Forces

9 Conclusion

Summary

Market Segment as follows:
By Type
BA-0702
CDX-3379
Elgemtumab
ETBX-031
Others
By Application
Non-Small Cell Carcinoma
Solid Tumor
Melanoma
Colorectal Cancer
Others
By Company
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Etubics Corporation
F. Hoffmann-La Roche Ltd.
GamaMabs Pharma S.A.
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
ImmunoGen, Inc.
Kolltan Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc.
Merus B.V.
Novartis AG
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.
Sorrento Therapeutics, Inc.
Symphogen A/S
Takis S.r.l.
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.